Client News

Lindis Blood Care to Present Top Line Results from Clinical Certification Study REMOVE with CATUVAB® at NATA24 Annual Symposium

Revolutionising Nanoparticle Production: Technical Evaluation Introduces Cutting-Edge Formulation Technolog

CARBIOS Announces Fiscal-Year 2023 Financial Results and Confirms 2024 Calendar for Industrial and Commercial Roll-Out

AdrenoMed Receives FDA Fast Track Designation for Enibarcimab for Treatment of Septic Shock

CRS appoints Catherine Canales as new Chief Commercial Officer to fuel strategic development and international growth

ViGeneron Announces First Patient Dosed in Phase 1b Clinical Trial of VG901 for the Intravitreal Treatment of Retinitis Pigmentosa

Mainz Biomed Reports Full Year 2023 Financial Results

G.ST Antivirals Reports Start of Phase II Trial and Announces Appointment of Ronald Bruce Turner as New Chief Medical Officer

Medigene Presents Favorable Safety Profile of TCR-T Cells with Costimulatory Switch Protein at AACR Annual Meeting 2024

Data from Newron’s study 014/015 and an evenamide clinical development outlook presented at the 2024 Annual Congress of the Schizophrenia International Research Society (SIRS)